<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A70DD43E-4E9F-42DD-8EBE-E679598BB5E9"><gtr:id>A70DD43E-4E9F-42DD-8EBE-E679598BB5E9</gtr:id><gtr:firstName>B</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Field</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6667"><gtr:id>FDD0FEDE-FCB1-446C-BED7-3AA455A001C0</gtr:id><gtr:title>Regulation of energy balance by a gonadotrophin-related neurotransmitter</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6667</gtr:grantReference><gtr:abstractText>Obesity is a major health problem for the population of this and many other countries. Research has shown that appetite and energy expenditure are influenced by hormones and other signals from many different parts of the body, including fat stores, the stomach and intestines. These signals are processed in an area of the brain known as the hypothalamus which regulates eating behaviour. The regulatory mechanisms within the hypothalamus are still being identified yet will be vital to develop new treatments for obesity. 

It has recently been shown that a chemical, known as GnRH-II, is found in the appetite regulating centres of the hypothalamus and powerfully inhibits appetite. This research project, to be carried out in the Imperial College Faculty of Medicine at the Hammersmith Hospital, will investigate the effects of GnRH-II on appetite and energy expenditure. Understanding the physiology of this system is the first step in tackling the obesity epidemic.</gtr:abstractText><gtr:technicalSummary>Gonadotrophin releasing hormone type II (GnRH-II) is a novel neurotransmitter with functions distinct from those of GnRH type I. The sequence of GnRH-II is identical in mammals and all other vertebrates examined suggesting an important physiological role. In rodent and monkey GnRH-II is found at high concentrations in the hypothalamic nuclei regulating food intake. Intracerebroventricular injection of GnRH-II reduces food intake in ad libitum-fed musk shrews. I have shown in pilot studies that 20 nmol GnRH-II administered by intracerebroventricular injection reduces food intake in male Wistar rats (see figure 1).

I hypothesise that GnRH-II plays a role in regulating energy balance. To investigate this I intend to determine:

1. the distribution of GnRH-II expression in the hypothalamus. 
2. the effect of alterations in energy balance on GnRH-II expression.
3. the acute effect of administration of GnRH-II or its antagonist on food intake.
4. the principal sites of action of GnRH-II.
5. the long-term effects of altered expression of GnRH-II on energy balance and body composition.

These investigations will establish the physiological role of GnRH-II in energy homeostasis.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>227000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Life Sciences</gtr:department><gtr:description>Neural interfaces</gtr:description><gtr:id>7273A21F-6941-4829-B5DA-42FE06DB95CF</gtr:id><gtr:impact>DOI: 10.1007/s10404-010-0740-y
EU Synergy grant awarded 2013</gtr:impact><gtr:outcomeId>EqU7bpeQHxe-1</gtr:outcomeId><gtr:partnerContribution>Providing engineering expertise to develop novel neural interfaces</gtr:partnerContribution><gtr:piContribution>Providing physiological and medical expertise to develop novel neural interfaces</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Short film</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>BF70B96C-78F2-4CD8-8389-EFC90FBECFCB</gtr:id><gtr:impact>Webcast hence unaware of effects on audience!

See above.</gtr:impact><gtr:outcomeId>fxR7ZApp2kp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Bromley</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>2D06E431-425B-4166-A924-38CFFA1B90E2</gtr:id><gtr:impact>Presentation and question-and-answer session for schoolchildren considering career in science and medicine

Several awaiting results of university applications...</gtr:impact><gtr:outcomeId>71F2F908E5E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2747155</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Studies Grant</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2C303CDA-99D4-46F9-A5BA-E3C12D3595AA</gtr:id><gtr:outcomeId>qsb1CmPQuLM0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>179787</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>NIHR Biomedical Research Centre grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D3082354-CFFC-4DC9-9CEF-509AFCC95BB6</gtr:id><gtr:outcomeId>E2mimei2prs0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Walport Clinical Lectureship</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>E905F4A7-C61A-490E-8A59-C4ABF8CA741F</gtr:id><gtr:outcomeId>1DB66198FC40</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>73650</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Healthcare NHS Charity</gtr:department><gtr:description>Imperial College Healthcare Charity Research Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Imperial College Healthcare NHS Trust</gtr:fundingOrg><gtr:id>CB11ECF4-4F38-4A8B-9056-FCC611CE49BF</gtr:id><gtr:outcomeId>626859F99E10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>This is an injectable anti-obesity agent which may have use in treatment of diabetes as well</gtr:description><gtr:id>A3235E0A-3E60-40E6-8552-8704777FD79E</gtr:id><gtr:impact>First time in human study clinical phase complete, database about to be locked.</gtr:impact><gtr:outcomeId>BEFC119D289</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>anti-obesity agent</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1089DF69-3AF1-4468-AB47-B3F880A70A62</gtr:id><gtr:title>Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420.</gtr:title><gtr:parentPublicationTitle>British journal of clinical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b506e62dbe7269359b599b222c300632"><gtr:id>b506e62dbe7269359b599b222c300632</gtr:id><gtr:otherNames>Tan TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0306-5251</gtr:issn><gtr:outcomeId>jgBinprxgg5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9A9A59A-D016-484B-9A54-67A8C7D45FFE</gtr:id><gtr:title>A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/675d66e21c3e06a30bf1f6f1122cddbf"><gtr:id>675d66e21c3e06a30bf1f6f1122cddbf</gtr:id><gtr:otherNames>Addison ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>XXkUpXqyv7G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80C3ACB-FF9F-45F1-822E-58746A31090A</gtr:id><gtr:title>Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e68d617e8f41a6c4986982da70f7c539"><gtr:id>e68d617e8f41a6c4986982da70f7c539</gtr:id><gtr:otherNames>Liu YL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>i2a1AhyRaBX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0B65F9E-438F-4E08-AFAD-490203F70E7B</gtr:id><gtr:title>PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c55288fe58ddc7d1d9b8fbe3a6ca9e3c"><gtr:id>c55288fe58ddc7d1d9b8fbe3a6ca9e3c</gtr:id><gtr:otherNames>Field BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>M1vdzUtkeeh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5021D27-65C0-44C3-B423-2CA3F14535DE</gtr:id><gtr:title>Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cc733ff8d9329ef2e9c3daaa9857061"><gtr:id>3cc733ff8d9329ef2e9c3daaa9857061</gtr:id><gtr:otherNames>Druce MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>UveTyeVnFog</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90396C0B-1E1C-44B6-818F-27AF21E5645D</gtr:id><gtr:title>Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI).</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec76773f29df5ffe9ec135a7ce62f6f1"><gtr:id>ec76773f29df5ffe9ec135a7ce62f6f1</gtr:id><gtr:otherNames>Parkinson JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>h3o31MnaB69</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6667</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>